M&A · Tech · Services-Computer Programming Services
IKS Health to acquire TruBridge, Inc.
Announced Apr 23, 2026 · Closed Jul 9, 2026
Deal value$391MEV $531M
Premium14.7%To unaffected price
EV / Adj. EBITDA9.0x1.5x EV / Revenue
ConsiderationAll cash$26.25 per share
Transaction
- Acquirer
- IKS Health
- Target
- TruBridge, Inc. (TBRG)
- Buyer type
- Strategic
- Offer price per share
- $26.25
- Enterprise value
- $531M
- Status
- Closed Jul 9, 2026
Deal protections
- Break fee (target pays)
- $12.3M · 3.1%
- Reverse fee (buyer pays)
- $24.6M · 6.3%
- Go-shop
- No-shop
- Financing
- Committed · Citigroup, Deutsche Bank, JPMorgan
Advisors
- To the acquirer
- JPMorgan, Citigroup
- To the target
- Solomon Partners
Sector context · Tech
- Comparable deals
- 70 in the prior 24 months
- Premium
- 14.7% vs. 40.0% sector median
- EV / Adj. EBITDA
- 9.0x vs. 16.7x sector median
- Break fee
- 3.1% vs. 3.0% sector median
Timeline
- AnnouncedApr 23, 2026
- Proxy filedMay 21, 2026
- Definitive proxyJun 4, 2026
- Shareholder voteJul 7, 2026
- ClosedJul 9, 2026
Valuation · fairness opinions
Trading comparables$14.00$32.31
Trading comparables$15.52$42.64
Precedent transactions$8.89$48.47
Precedent transactions$12.19$36.14
Discounted cash flow$24.11$39.81
Offer $26.25
Implied value per TruBridge, Inc. share by analysis · DCF discount rate 12%–13%.